The efficacy and safety of oral Tamsulosin controlled absorption system (OCAS) for the treatment of lower urinary tract symptoms due to bladder outlet obstruction associated with benign prostatic hyperplasia: an open-label preliminary study
AIMS: Tamsulosin, a superselective subtype alpha 1a and 1d blocker, is used for the treatment of male lower urinary tract symptoms (LUTS) commonly caused by benign prostatic hyperplasia (BPH). This prospective study evaluated the efficacy and safety of a new formulation, Tamsulosin OCAS® (Oral Contr...
Main Authors: | Bannakij Lojanapiwat, Sompol Permpongkosol |
---|---|
Format: | Article |
Language: | English |
Published: |
Sociedade Brasileira de Urologia
2011-08-01
|
Series: | International Brazilian Journal of Urology |
Subjects: | |
Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382011000400005 |
Similar Items
-
Does bladder outlet obstruction affect distance between the ureteric orifices in patients with benign prostate hyperplasia?
by: Cüneyt Özden, et al.
Published: (2009-01-01) -
Efficacy of holmium laser enucleation of the prostate (HoLEP) in men with bladder outlet obstruction (BOO) and non-neurogenic bladder dysfunction
by: Jong Hyun Pyun, et al.
Published: (2017-09-01) -
The Effectiveness of Silodosin for Nocturnal Polyuria in Elderly Men With Benign Prostatic Hyperplasia: A Multicenter Study
by: Young Won Kim, et al.
Published: (2015-09-01) -
Botulinum toxin and benign prostatic hyperplasia
by: Lay Guat Ng
Published: (2018-01-01) -
Tamsulosin and Dementia in old age: is there any relationship?
by: Rebecca Renata Lapenda do Monte, Karina de Andrade Vidal Costa, Arnaldo Santiago Nunes Junior, Am lia Cinthia Meneses R go, Irami Ara jo Filho
Published: (2019-10-01)